|
|
|
Volumn 2, Issue 5, 2008, Pages 146-147
|
|
Decitabine in myeloid malignancies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
5 METHYLCYTOSINE;
DNA;
DNA METHYLTRANSFERASE;
DNA METHYLTRANSFERASE INHIBITOR;
GROWTH FACTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
BLOOD TRANSFUSION;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CHRONIC MYELOMONOCYTIC LEUKEMIA;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
CYTOTOXICITY;
DISEASE COURSE;
DNA METHYLATION;
DOSE RESPONSE;
DRUG EFFICACY;
ELDERLY CARE;
ENZYME ACTIVATION;
EPIGENETICS;
HEMATOPOIETIC STEM CELL;
HUMAN;
LEUKEMOGENESIS;
MORTALITY;
MULTIPLE CYCLE TREATMENT;
MYELODYSPLASTIC SYNDROME;
PATIENT CARE;
RECOMMENDED DRUG DOSE;
RISK FACTOR;
TREATMENT RESPONSE;
|
|
EID: 54249149790
PISSN: 19707339
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
